PERIGON Pivotal Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1312 participants.
Also called NCT02088554
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,312 participants
- Registry
-
NCT02088554
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Canada, France, Germany, Italy, Netherlands, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02088554. Allocation not applicable; no masking; primary purpose treatment. Start 2014-05-12 (actual); primary completion 2023-04-17 (actual). Results posted on 2024-06-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PERIGON Pivotal Trial
- Acronym
- PERIGON
- Condition
- Aortic Stenosis
- Intervention (Device)
- Model 400 aortic valve bioprosthesis
- Lead sponsor
- Medtronic Cardiac Surgery
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct02088554- Content hash
d70e431f8eb27b1392ce06244888bf4b1aa91050e40a9c4ae8092e563d0aa8f3